US Health Officials Recommend Pfizer or Moderna Vaccines Over J&J Shot Due to Rare but Serious Blood Clot Risk

Strategic Insights -

US health officials have recommended that most Americans opt for the Pfizer or Moderna COVID-19 vaccines instead of the Johnson & Johnson shot, citing the rare but serious blood clot risk associated with J&J's vaccine. The decision was made by the Centers for Disease Control and Prevention (CDC) after a panel of advisers reviewed new data on vaccine safety.

Key Takeaways:

  • The CDC's advisers unanimously agreed to give preference to the Pfizer and Moderna vaccines over the J&J shot due to the risk of rare but serious blood clots, which have caused nine confirmed deaths in the US.
  • The Pfizer and Moderna vaccines do not carry the same risk as the J&J shot, and also appear to be more effective, according to the CDC's advisers.
  • The J&J vaccine is still available for those who want it or have a severe allergy to the other options, but the CDC's director, Dr. Rochelle Walensky, has accepted the panel's advice to give preference to the Pfizer and Moderna vaccines.
  • Since the vaccine rollout began, more than 200 million Americans have been fully vaccinated, including about 16 million who received the J&J shot.
  • New data on vaccine safety has persuaded the panel that while the blood clots linked to J&J's vaccine remain very rare, they are still occurring and not just in younger women as originally thought.

Statistics:

  • 9 confirmed deaths due to blood clots linked to the J&J vaccine in the US.
  • 54 confirmed clot cases, with 37 in women and 17 in men.
  • 9 deaths, including 2 men, with 2 additional deaths suspected.
  • 16 million Americans who received the J&J shot.
  • 7 million doses of Pfizer vaccine has been given to younger children, with few reported serious side effects.
  • 80 reported cases of serious side effects, with about 10 involving a form of inflammation in male teens and young adults.

Sources:

  • Associated Press: "US health officials recommend Pfizer, Moderna over J&J vaccine due to rare clot risk"
  • Centers for Disease Control and Prevention: "COVID-19 Vaccines for the General Public"
  • Food and Drug Administration: "Communication with Healthcare Providers"